andy cohen glp 1 explains why he started microdosing a GLP-1 Andy Cohen admits to 'micro-dosing'

Identification of Small-Molecule Frequent Hitters of Glutathione [PMID: 27044684] Laboratory literature summary: Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase-Glutathione Interaction

Standards of Care in Diabetes2024. Diabetes Care , 47(Suppl 1)

pre- and on-treatment measured weights were available in only 64.6% of patients treated with a GLP-1 RA

doi: 10.3390/biom11020217

My suspicion would be that any benefit that somebody got from this would be much more likely due to a placebo effect than actual increased production of GLP-1, says Dr

Still, compounded versions are not FDA-approved brand products